BSEInsider Trading / SAST9 Sept 2026 · 9 Sept 2026, 07:59 pm

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta

Sudarshan Pharma Industries Ltd · 543828

✦ AI SummaryRelated Party

Sudarshan Pharma Industries Ltd has received revised disclosures under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.